VC, G., CE, N., CJ, B., & AC, F. (2023). Letter: Determining priorities for patients with faecal incontinence and irritable bowel syndrome-authors' reply. Alimentary pharmacology & therapeutics, 58(1), 139. https://doi.org/10.1111/apt.17571
Chicago Style (17th ed.) CitationVC, Goodoory, Ng CE, Black CJ, and Ford AC. "Letter: Determining Priorities for Patients with Faecal Incontinence and Irritable Bowel Syndrome-authors' Reply." Alimentary Pharmacology & Therapeutics 58, no. 1 (2023): 139. https://doi.org/10.1111/apt.17571.
MLA (9th ed.) CitationVC, Goodoory, et al. "Letter: Determining Priorities for Patients with Faecal Incontinence and Irritable Bowel Syndrome-authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 58, no. 1, 2023, p. 139, https://doi.org/10.1111/apt.17571.